BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20053567)

  • 21. 99mTc-labeled C2A domain of synaptotagmin I as a target-specific molecular probe for noninvasive imaging of acute myocardial infarction.
    Zhao M; Zhu X; Ji S; Zhou J; Ozker KS; Fang W; Molthen RC; Hellman RS
    J Nucl Med; 2006 Aug; 47(8):1367-74. PubMed ID: 16883018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin.
    von Guggenberg E; Behe M; Behr TM; Saurer M; Seppi T; Decristoforo C
    Bioconjug Chem; 2004; 15(4):864-71. PubMed ID: 15264875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monitoring apoptosis in real time.
    Green AM; Steinmetz ND
    Cancer J; 2002; 8(2):82-92. PubMed ID: 11999952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. XTEN-annexin A5: XTEN allows complete expression of long-circulating protein-based imaging probes as recombinant alternative to PEGylation.
    Haeckel A; Appler F; Figge L; Kratz H; Lukas M; Michel R; Schnorr J; Zille M; Hamm B; Schellenberger E
    J Nucl Med; 2014 Mar; 55(3):508-14. PubMed ID: 24549285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preclinical validation of 99mTc-annexin A5-128 in experimental autoimmune myocarditis and infective endocarditis: comparison with 99mTc-HYNIC-annexin A5.
    Benali K; Louedec L; Azzouna RB; Merceron O; Nassar P; Al Shoukr F; Petiet A; Barbato D; Michel JB; Sarda-Mantel L; Le Guludec D; Rouzet F
    Mol Imaging; 2014; 13():. PubMed ID: 25431156
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [99mTc]Annexin V-128 SPECT Monitoring of Splenic and Disseminated Listeriosis in Mice: a Model of Imaging Sepsis.
    Hardy JW; Levashova Z; Schmidt TL; Contag CH; Blankenberg FG
    Mol Imaging Biol; 2015 Jun; 17(3):345-54. PubMed ID: 25416406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclotron Production of (99m)Tc using (100)Mo2C targets.
    Richards VN; Mebrahtu E; Lapi SE
    Nucl Med Biol; 2013 Oct; 40(7):939-45. PubMed ID: 23890695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Questioning the value of (99m)Tc-HYNIC-annexin V based response monitoring after docetaxel treatment in a mouse model for hereditary breast cancer.
    Beekman CA; Buckle T; van Leeuwen AC; Valdés Olmos RA; Verheij M; Rottenberg S; van Leeuwen FW
    Appl Radiat Isot; 2011 Apr; 69(4):656-62. PubMed ID: 21227707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Noninvasive detection of programmed cell loss with 99mTc-labeled annexin A5 in heart failure.
    Kietselaer BL; Reutelingsperger CP; Boersma HH; Heidendal GA; Liem IH; Crijns HJ; Narula J; Hofstra L
    J Nucl Med; 2007 Apr; 48(4):562-7. PubMed ID: 17401092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imaging and dosimetry of 99mTc EC annexin V: preliminary clinical study targeting apoptosis in breast tumors.
    Kurihara H; Yang DJ; Cristofanilli M; Erwin WD; Yu DF; Kohanim S; Mendez R; Kim EE
    Appl Radiat Isot; 2008 Sep; 66(9):1175-82. PubMed ID: 18308577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Annexin V imaging detects diabetes-accelerated apoptosis and monitors the efficacy of benfotiamine treatment in ischemic limbs of mice.
    Jung KH; Lee JH; Park JW; Paik JY; Quach CH; Lee EJ; Lee KH
    Mol Imaging; 2014; 13():1-7. PubMed ID: 24824853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary biological evaluation of ¹⁸F-FBEM-Cys-Annexin V a novel apoptosis imaging agent.
    Lu C; Jiang Q; Hu M; Tan C; Yu H; Hua Z
    Molecules; 2015 Mar; 20(3):4902-14. PubMed ID: 25789822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apoptosis-detecting radioligands: current state of the art and future perspectives.
    Lahorte CM; Vanderheyden JL; Steinmetz N; Van de Wiele C; Dierckx RA; Slegers G
    Eur J Nucl Med Mol Imaging; 2004 Jun; 31(6):887-919. PubMed ID: 15138718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Annexin V expression and anti-annexin V antibodies in type 1 diabetes.
    Bakar F; Unlütürk U; Başkal N; Nebioğlu S
    J Clin Endocrinol Metab; 2014 Mar; 99(3):932-7. PubMed ID: 24423325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticancer therapy and apoptosis imaging.
    Yang TJ; Haimovitz-Friedman A; Verheij M
    Exp Oncol; 2012 Oct; 34(3):269-76. PubMed ID: 23070012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A dual-labeled Annexin A5 is not suited for SPECT imaging of brain cell death in experimental murine stroke.
    Zille M; Harhausen D; De Saint-Hubert M; Michel R; Reutelingsperger CP; Dirnagl U; Wunder A
    J Cereb Blood Flow Metab; 2014 Sep; 34(9):1568-70. PubMed ID: 24984896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secretion of Recombinant Human Annexin V in Fusion with the Super Folder GFP for Labelling Phosphatidylserine-Exposing Membranes.
    Twair A; Kassem I; Murad H; Abbady AQ
    J Membr Biol; 2021 Apr; 254(2):175-187. PubMed ID: 33604692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Looking through the vascular normalization window: timing antiangiogenic treatment and chemotherapy with (99m)Tc-annexin A5.
    Lewis MR
    J Nucl Med; 2011 Nov; 52(11):1670-2. PubMed ID: 21994408
    [No Abstract]   [Full Text] [Related]  

  • 39. Imaging radiotherapy-induced apoptosis.
    Haimovitz-Friedman A; Yang TJ; Thin TH; Verheij M
    Radiat Res; 2012 Apr; 177(4):467-82. PubMed ID: 22348249
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.